← all drugs
Semaglutide Tablet
being discontinued · Endocrinology/Metabolism · Snapshot: 2026-10-09
- Manufacturers listed
- Novo Nordisk, Inc.
- Machine-readable
- JSON for this drug
Presentations (3)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Rybelsus, Tablet, 14 mg (NDC 0169-4314-30) | Novo Nordisk, Inc. | unknown | 06/04/2026 |
| Rybelsus, Tablet, 3 mg (NDC 0169-4303-30) | Novo Nordisk, Inc. | unknown | 06/04/2026 |
| Rybelsus, Tablet, 7 mg (NDC 0169-4307-30) | Novo Nordisk, Inc. | unknown | 06/04/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.